NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) FCF Margin (2025 - 2026)

Updated

NRX Pharmaceuticals (NRXP) reported FCF Margin of -808.36% for Q2 2026, down 417.45 percentage points from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) FCF Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, NRX Pharmaceuticals' FCF Margin came in at -578.05%; for FY2025, it came in at -1152.00%.

  • Five-year quarterly FCF Margin spans a low of -1195.04% in Q3 2025 and a high of -377.62% in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -390.91% (Q1 2026), -377.62% (Q4 2025) and -1195.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.82%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 18.33%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 26.96%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 43.05%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 34.72%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.70%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 44.00%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 30.39%
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 -808.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -808.36%
Mar 31, 2026 -390.91%
Dec 31, 2025 -377.62%
Sep 30, 2025 -1,195.04%
API Access

NRX Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NRXP&period=max&api_key=YOUR_API_KEY